2011 Excitatory Synapses and Brain Function GRC
2011 Excitatory Synapses and Brain Function GRC
批准号:
8459583
负责人:
ROGER A NICOLL
金额:
$2.25万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2015-08-31
关键词:
Alzheimer&aposs DiseaseAttentionAutistic DisorderBehaviorBiologicalBrainBrain regionCellsCommunicationDefectDevelopmentDiseaseEnvironmentEpilepsyExcitatory SynapseFacultyFunctional disorderFutureGoalsHumanImpairmentInstitutesMental DepressionMental HealthMental disordersMethodsMissionMolecularMolecular StructureNational Institute of Drug AbuseNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNeuraxisNeurosciencesParkinson DiseaseParticipantPharmaceutical PreparationsPostdoctoral FellowPropertyRequest for ProposalsResearchSchizophreniaScientistShapesSignal TransductionSiteStrokeStructural BiologistSubstance AddictionSubstance abuse problemSynapsesTechnologyTraumatic Brain InjuryUnited StatesUnited States National Institutes of HealthUpdateWorkdesigndriving forcegraduate studentimprovedinformation processinginsightmultidisciplinarynervous system disorderneural circuitnovel strategiesprogramssoundsymposiumsynaptic function
中文摘要
描述(由申请人提供):该提案要求R13支持长期以来,出席人数众多,广受欢迎的戈登兴奋性突触和脑功能研究会议(GRC)。突触是我们理解电路功能和行为的核心。在中枢神经系统中,兴奋性突触代表了通过局部回路进行信息处理和大脑区域之间通信的主要方式。突触作为许多常用处方药的作用部位,其破坏导致许多神经和精神疾病。这些疾病包括精神分裂症、自闭症、抑郁症、药物滥用和成瘾、帕金森病、阿尔茨海默病、创伤性脑损伤、中风和癫痫。在某些情况下,突触功能障碍是疾病的原因,而在其他情况下,它代表了一个或多个潜在的分子缺陷的下游后遗症。无论哪种情况,对突触的形成、结构、分子组织、信号功能和可塑性的基本理解对于减轻人类神经系统疾病的负担以及预测和改善心理健康至关重要。这次会议是独一无二的,其重点是兴奋性突触,并在其多学科组的参与者,包括结构生物学家,分子和发育生物学家,细胞生物学家,生物化学家,细胞/分子成像,生物药理学家和神经生理学家。会议旨在将兴奋性突触功能的基本见解与疾病中发生的突触功能障碍以及物质滥用中发生的适应不良可塑性联系起来。会议的目标是从主题方法中识别和强调对突触功能和功能障碍的基本新见解。该计划旨在突出尖端方法,并在基础神经科学的合理生物学框架内激发新的概念,方法和技术。这次会议将使全世界的科学专家在一个有利于讨论和交流思想的环境中聚集一堂。这次会议上的思想交流是该领域的推动力。我们预计2011年关于兴奋性突触和脑功能的GRC将塑造未来的科学方向,并为NIH多个研究所(包括NIMH、NINDS、NIDA和NIA)的使命提供关键支持。
英文摘要
DESCRIPTION (provided by applicant): This proposal requests R13 support for a longstanding, well-attended, and well-received Gordon Research Conference (GRC) on Excitatory Synapses and Brain Function. The synapse is central to our understanding of circuit function and behavior. In the central nervous system, excitatory synapses represent the primary means of information processing by local circuits and communication between brain regions. Synapses serve as the site of action for many commonly prescribed medications and their disruption contributes to many neurological and psychiatric disorders. These include schizophrenia, autism, depression, substance abuse and addiction, Parkinson's disease, Alzheimer's disease, traumatic brain injury, stroke and epilepsy. In some cases, synaptic dysfunction is causal in disease, whereas in other cases it represents the downstream sequelae of one or more underlying molecular defects. In either case, a fundamental understanding of the formation, structure, molecular organization, signaling function, and plasticity of synapses is essential to progress in lessening the burden of human neurological disease and for predicting and improving mental health. This conference is unique in its focus on the excitatory synapse, and in its multidisciplinary group of participants including structural biologists, molecular and developmental biologists, cell biologists, biochemists, cell/molecular imagers, biophysicists and neurophysiologists. The conference is intended to relate fundamental insights in excitatory synaptic function to the impairments in synaptic function that occur in disease, as well as the maladaptive plasticity that occurs in substance abuse. The goal of the conference is to identify and highlight fundamental new insights into synaptic function and dysfunction from a thematic approach. The program has been designed to also highlight cutting edge approaches and to stimulate new concepts, methods and technologies within a sound biological framework of fundamental neuroscience. The conference will bring together expert scientists worldwide in an environment that is conducive to discussion and exchange of ideas. The exchange of ideas at this conference has been a driving force for the field. We expect the 2011 GRC on Excitatory Synapses and Brain Function will shape future scientific directions, and provide critical support for the mission of multiple institutes at NIH including NIMH, NINDS, NIDA and NIA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The synaptic cleft and glutamate receptor trafficking
-
批准号:10196921
-
项目类别:
-
资助金额:$58.45万
-
财政年份:2018
-
负责人:ROGER A NICOLL
-
依托单位:
The synaptic cleft and glutamate receptor trafficking
-
批准号:10449275
-
项目类别:
-
资助金额:$58.43万
-
财政年份:2018
-
负责人:ROGER A NICOLL
-
依托单位:
2011 Excitatory Synapses and Brain Function GRC
-
批准号:8267002
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ROGER A NICOLL
-
依托单位:
THE ROLE OF ACTIVITY IN SCULPTING NEURONAL FORM AND FUNCTION
-
批准号:8361932
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2011
-
负责人:ROGER A NICOLL
-
依托单位:
2011 Excitatory Synapses and Brain Function GRC
-
批准号:8644923
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ROGER A NICOLL
-
依托单位:
THE ROLE OF ACTIVITY IN SCULPTING NEURONAL FORM AND FUNCTION
-
批准号:8169648
-
项目类别:
-
资助金额:$0.84万
-
财政年份:2010
-
负责人:ROGER A NICOLL
-
依托单位:
Synaptic Glutamate Receptor Trafficking
-
批准号:8660322
-
项目类别:
-
资助金额:$51.55万
-
财政年份:2007
-
负责人:ROGER A NICOLL
-
依托单位:
Synaptic Glutamate Receptor Trafficking
-
批准号:8529614
-
项目类别:
-
资助金额:$49.21万
-
财政年份:2007
-
负责人:ROGER A NICOLL
-
依托单位:
Synaptic Glutamate Receptor Trafficking.
-
批准号:8077998
-
项目类别:
-
资助金额:$55.21万
-
财政年份:2007
-
负责人:ROGER A NICOLL
-
依托单位:
Synaptic Glutamate Receptor Trafficking.
-
批准号:7625908
-
项目类别:
-
资助金额:$54.97万
-
财政年份:2007
-
负责人:ROGER A NICOLL
-
依托单位:
Synaptic Glutamate Receptor Trafficking.
-
批准号:7845626
-
项目类别:
-
资助金额:$55.77万
-
财政年份:2007
-
负责人:ROGER A NICOLL
-
依托单位:
Synaptic Glutamate Receptor Trafficking
-
批准号:8372693
-
项目类别:
-
资助金额:$56.8万
-
财政年份:2007
-
负责人:ROGER A NICOLL
-
依托单位:
CELLULAR & BIOCHEMICAL MECHANISMS UNDERLYING MOSSY FIBER LONG TERM POTENTIATION
-
批准号:7470544
-
项目类别:
-
资助金额:$19.49万
-
财政年份:2007
-
负责人:ROGER A NICOLL
-
依托单位:
Synaptic Glutamate Receptor Trafficking.
-
批准号:7246989
-
项目类别:
-
资助金额:$53.18万
-
财政年份:2007
-
负责人:ROGER A NICOLL
-
依托单位:
CELLULAR & BIOCHEMICAL MECHANISMS UNDERLYING MOSSY FIBER LONG TERM POTENTIATION
-
批准号:7086846
-
项目类别:
-
资助金额:$18.82万
-
财政年份:2005
-
负责人:ROGER A NICOLL
-
依托单位:
AMPA Receptor Subunits and Plasticity
-
批准号:8035423
-
项目类别:
-
资助金额:$37.66万
-
财政年份:2004
-
负责人:ROGER A NICOLL
-
依托单位:
Synaptic plasticity regulated by stargazin-like gamma-8
-
批准号:7019189
-
项目类别:
-
资助金额:$29.96万
-
财政年份:2004
-
负责人:ROGER A NICOLL
-
依托单位:
Synaptic plasticity regulated by stargazin-like gamma-8
-
批准号:7195729
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2004
-
负责人:ROGER A NICOLL
-
依托单位:
AMPA Receptor Subunits and Plasticity
-
批准号:7796882
-
项目类别:
-
资助金额:$38.04万
-
财政年份:2004
-
负责人:ROGER A NICOLL
-
依托单位:
AMPA Receptor Subunits and Plasticity
-
批准号:8335737
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2004
-
负责人:ROGER A NICOLL
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: